EUVIMED · CrossrefZeitschrift
Nature Reviews Immunology
ISSN 1474-1733 · Springer Science and Business Media LLC
Neueste Artikel
l-carnitine links red meat consumption to inflammation
Activated TILs are restricted by iron availability in pancreatic cancer
Autoantibodies tip the balance towards preterm birth
A division of labour for PD-1 ligands
Peripheral neuroimmune dialogues underlying pain states
Hallmarks and correlates of effective adoptive cell immunotherapy for cancer
T cell engagers in autoimmune diseases
New insights into progenitor exhausted T cell populations
Priming systemic immunity against glioblastoma
Granzyme K-expressing CD8+ T cells, complement activation and histotoxic immunity
Comparative insights into the apoptosome, inflammasomes and PIDDosome
Immunity: from specificity to physiological integration
Living in the age of inflammation: the reverse hygiene hypothesis
Interleukin-33 and its receptor: multifaceted roles and emerging therapeutic potential
Pathophysiological roles of monocytes and macrophages in cancer
Immune surveillance and immune evasion of senescent cells
Renaissance of antiviral CD8+ T cell immunity in vaccination and disease
Cytokine multimerization: when more is more and sometimes less
cDC1s license CD8+ T cell-mediated neurodegeneration
The challenge and promise of studying human antigen-specific T cells
A guide to CAR T cell therapies: development, current status and future prospects
Macrophages in embryonic development
The ageing immune system as a driver of systemic ageing
Harnessing mucosal immunity for protective vaccines
Progress in the development of cytokine armoured CAR T cells
Kupffer cells in liver homeostasis and disease: from immune sentinels to metabolic gatekeepers
Inflame and restrain — the paradoxical roles of IL-12 and IL-23 in immunity
Metabolites as signalling molecules in the tumour immune microenvironment
Fibroblasts as regulators of lung immunity, repair and fibrosis
Ubiquitination and autophagy in host–pathogen interactions: from immune surveillance to therapeutic targeting
EUVIMED